Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Neu

Showing results (151-160 of 1,127) with videos related to

Pageof 113
Sort By:
Medical Times|February 1, 1975
Just how good is amoxicillin?H C Neu
Infection Control : IC|January 1, 1986
Cost effective blood cultures--is it possible or impossible to modify behavior?H C Neu
Hospital Practice (Office Ed.)|June 15, 1990
Antibacterial therapy: problems and promises, Part IIH C Neu
Journal of Clinical Pharmacology|May 1, 1990
Third generation cephalosporins: safety profiles after 10 years of clinical useH C Neu
Journal of the American Academy of Dermatology|May 1, 1990
Beta-lactamases, beta-lactamase inhibitors, and skin and skin-structure infectionsH C Neu
Pharmacology & Therapeutics|January 1, 1985
The role of beta-lactamase inhibitors in chemotherapyH C Neu
Drugs|January 1, 1975
New broad-spectrum penicillinsH C Neu
Antimicrobial Agents and Chemotherapy|September 1, 1976
Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibioticsJ C Neu
The American Journal of Medicine|June 24, 1996
Safety of cefepime: a new extended-spectrum parenteral cephalosporinH C Neu
Journal of Clinical Pharmacology|August 1, 1992
Once-daily oral antimicrobial therapy: is a consensus possible?H C Neu
Pageof 113

Showing results (151-160 of 1,127) with videos related to

Sort By:
Pageof 113
Medical Times|February 1, 1975
Just how good is amoxicillin?H C Neu
Infection Control : IC|January 1, 1986
Cost effective blood cultures--is it possible or impossible to modify behavior?H C Neu
Hospital Practice (Office Ed.)|June 15, 1990
Antibacterial therapy: problems and promises, Part IIH C Neu
Journal of Clinical Pharmacology|May 1, 1990
Third generation cephalosporins: safety profiles after 10 years of clinical useH C Neu
Journal of the American Academy of Dermatology|May 1, 1990
Beta-lactamases, beta-lactamase inhibitors, and skin and skin-structure infectionsH C Neu
Pharmacology & Therapeutics|January 1, 1985
The role of beta-lactamase inhibitors in chemotherapyH C Neu
Drugs|January 1, 1975
New broad-spectrum penicillinsH C Neu
Antimicrobial Agents and Chemotherapy|September 1, 1976
Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibioticsJ C Neu
The American Journal of Medicine|June 24, 1996
Safety of cefepime: a new extended-spectrum parenteral cephalosporinH C Neu
Journal of Clinical Pharmacology|August 1, 1992
Once-daily oral antimicrobial therapy: is a consensus possible?H C Neu
Pageof 113